Evidence map›Paper›PMID 35928197›Full record

ArticleFuture healthcare journal2022

The role of wirelessly observed therapy in improving treatment adherence.

Kartik Kumar, Michael R Loebinger, Saira Ghafur

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future healthcare journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kartik KumarRoyal Brompton Hospital, London, UK and National Institute for Health Research Imperial Biomedical Research Centre clinical research fellow in respiratory medicine, National Heart and Lung Institute, London, UK.
Michael R LoebingerRoyal Brompton Hospital, London, UK and professor of practice (respiratory medicine), National Heart and Lung Institute, London, UK.
Saira GhafurSt Mary's Hospital, London, UK and lead for digital health, Institute of Global Health Innovation, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wirelessly observed therapy (WOT) offers a novel way of monitoring treatment adherence. In this article, we provide an overview of how this technology works and discuss the evidence for its clinical effectiveness in tuberculosis, hepatitis C virus infection, mental health and cardiovascular disease. We consider the acceptability of WOT to patients as well as potential issues relating to patient autonomy and data protection. We highlight the current limited data on its economic impact and reflect on its future role in patient care.

Indexed as

digital healthhealth policyingestible sensorstuberculosiswirelessly observed therapy

Identifiers

PMID35928197
PMCPMC9345231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.